High Spatial Resolution Chemical Imaging of Implant-Associated Infections with X-ray Excited Luminescence Chemical Imaging Through Tissue
September 30th, 2022
Here, we present a protocol for high-resolution optical detection of chemical information around implanted medical devices with X-ray excited luminescence chemical imaging (XELCI). This novel imaging technique is developed in our lab which enables studying implant-associated infection biochemistry.
Overview
This article presents a protocol for high-resolution optical detection of chemical information around implanted medical devices using X-ray excited luminescence chemical imaging (XELCI). This innovative technique enables the study of biochemistry associated with implant-related infections.
Key Study Components
Area of Science
- Neuroscience
- Biomedical Engineering
- Infection Biology
Background
- Implant-associated infections pose significant challenges in medical treatments.
- Understanding the local chemical environment is crucial for effective monitoring and intervention.
- XELCI offers a novel approach to visualize biochemical changes.
- This technique can enhance our understanding of infection biochemistry around implants.
Purpose of Study
- To develop a method for imaging biochemical changes near implanted medical devices.
- To monitor the local chemical environment associated with infections.
- To provide high-resolution images of chemical concentration variations.
Methods Used
- Initialization of the imaging system with PMT cooler and software.
- Mapping of x-axis and y-axis to desired starting positions.
- Imaging and analysis of chemical information around implants.
- Demonstration of bacterial culturing procedures.
Main Results
- Successful imaging of biochemical changes around implant surfaces.
- High-resolution mapping of chemical concentrations achieved.
- Insights into the local chemical environment of implant-associated infections.
- Demonstrated feasibility of XELCI for future studies.
Conclusions
- XELCI is a promising technique for studying implant-associated infections.
- It allows for real-time monitoring of biochemical changes.
- This method could lead to improved strategies for managing infections around medical implants.
Frequently Asked Questions
Executive Industry Relevance
Implant-associated infections present a critical challenge in device-enabled therapies, where early detection of local biochemical changes is essential for intervention and device salvage. X-ray excited luminescence chemical imaging (XELCI) enables noninvasive, high-resolution mapping of chemical microenvironments at implant surfaces, supporting predictive confidence in infection monitoring. This capability strengthens translational continuity from preclinical infection models to device development pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of infection-driven biochemical changes at the device-tissue interface.
- Supports mechanistic de-risking by mapping local pH shifts linked to microbial colonization.
- Facilitates functional validation of infection biomarkers in situ.
Screening & Assay Development
- Provides a platform for quantitative, spatially resolved chemical readouts in preclinical models.
- Enables assay standardization for infection detection at implant surfaces and within bone.
- Supports reproducible evaluation of device coatings and antimicrobial strategies.
Translational & Preclinical Research
- Aligns with disease-relevant models by enabling in vivo monitoring of infection biochemistry.
- Bridges discovery and preclinical validation through noninvasive chemical imaging.
- Informs risk-adjusted advancement of device candidates based on infection response profiles.
Pipeline & Workflow Integration
XELCI integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven infection monitoring and supporting lead identification for device coatings or antimicrobial interventions.
- Discovery Biology: Maps biochemical signatures of infection, clarifying mechanistic pathways at the implant interface.
- Screening: Delivers quantitative, reproducible pH imaging for comparative evaluation of device modifications.
- Analytics: Provides spectral ratio outputs for robust statistical analysis of infection-associated changes.
- Translational Research: Maintains continuity from in vitro to in vivo infection models, supporting biomarker alignment.
- Enterprise Reuse: Establishes a reusable imaging platform for diverse implant and infection studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in infection detection and target validation at the device-tissue interface.
- Operational Value: Standardizes noninvasive chemical imaging workflows for reproducibility and scalability.
- Strategic Value: Enables earlier go/no-go decisions for device candidates based on infection risk profiles.
- Portfolio Impact: Supports risk-adjusted prioritization of device and antimicrobial strategies in development pipelines.
Implementation Considerations
- Requires expertise in optical imaging, X-ray instrumentation, and spectral analysis.
- Demands specialized hardware including PMT detectors, X-ray sources, and imaging enclosures.
- Necessitates cross-team standardization of sample preparation and imaging parameters.
- Adaptation across implant types and animal models may require protocol optimization.
- Imaging depth and tissue heterogeneity may limit resolution in certain preclinical scenarios.
Biopharma FAQs
Chapters in this video
0:04
Introduction
0:54
Initialize the System and Acquire a Plain Radiograph
2:25
Performing a Background Scan with the X-Ray Off
3:07
Performing a Sample Scan with the X-Ray on and Forming the Image
4:00
Culturing Bacteria for Imaging in Sterile Conditions
5:53
Results: Imaging the Intramedullary Rod Sensor in a Reamed Tibia of a Rabbit
6:44
Conclusion
